期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

在CHO细胞中表达具有高效成骨活性的BMP-2／7异源二聚体 被引量：4

Expression of BMP-2/7 Heterodimers with Potent Ability to Stimulate Osteogenic Differentiation in CHO Cells
下载PDF
导出
摘要 PCR扩增BMP-2与BMP-7的编码基因,利用重叠PCR以柔性肽(Gly4Ser)5编码序列将二者串连并克隆到质粒pIRESneo3上,转染CHO-K1细胞得到混合稳定克隆。ELISA检测培养液中BMP-2/7异源二聚体蛋白的表达水平为230.75±13.34ng/mL,以此为条件培养基处理成骨细胞株MC3T3,对照组为分别含有CHO-K1细胞及大肠杆菌表达的BMP-2同源二聚体以及PBS的条件培养基。结果发现碱性磷酸酶染色与茜素红染色差异明显,定量RT-PCR显示分子指标OC、ALP、Runx2与Osx的转录水平明显增高(P<0.05),Luciferase报告基因检测BMP/Smad通路活性较对照组升高明显(P<0.05)。首次设计构建了BMP-2/7异源二聚体蛋白,其成骨活性显著高于BMP-2同源二聚体。 Coding sequences of BMP-2 and BMP-7 were amplified using PCR and ligated with a DNA sequence encoding a flexible peptide （Gly4Ser）5. The fusion gene was inserted into plasmid pIRESneo3. The expression level of BMP2/7 heterodimers in the transfected CHO-K1 cells was 230,75±13.34 ng/mL. Culture medium of stably tansfected clone pool was collected as conditional medium to treat osteoblast MC3T3 cells. Staining of Alkalin phosphatase and Alizarin red demonstrated that the conditional medium significantly promoted osteogenic differentiation to a higher extent than BMP-2 homodimers expressed in either CHO-K1 cells or E. coll. Transcriptional levels of Osteogenic phenotype-related molecular markers such as OC, ALP, Runx2 and Osx were increased （P〈0.05）, and BMP/Smad signal activities were significantly enhanced by BMP-2/7 heterodimers, comparing with BMP-2 homodimers （P〈0.05）. The results demonstrate that BMP-2/7 heterodimers expressed in CHO-K1 cells have potent ability to stimulate osteogenic differentiation.
作者 潘秋辉 杨松海 孙奋勇
机构地区 中山大学附属第二医院医学研究中心 暨南大学生命科学技术学院生物工程研究所
出处 《生物工程学报》 CAS CSCD 北大核心 2008年第3期473-479,共7页 Chinese Journal of Biotechnology
基金 广州市科技计划项目(No.2006Z1-E0031,No.2006Z3-E0791)~~
关键词 骨形态发生蛋白 异源二聚体 成骨细胞 分化 bone morphogenefic protein, heterodimer, osteoblast, differentiation
分类号 Q78 [生物学—分子生物学]
  • 相关文献

参考文献13

  • 1Kofron MD, Li X, Laurencin CT. Protein- and gene-based tissue engineering in bone repair. Current Opinion in Biotechnology, 2004, 15: 399-405.
  • 2Groppe J, Greenwald J, Wiater E, et al. Structural basis of BMP Signaling inhibition by the cystine knot protein Noggin. Nature, 2002, 420 (12): 636-642.
  • 3Israel DI, Nove J, Kerns KM, et al. Wozney JMHeterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors, 1996, 13: 291-300.
  • 4Hazama M, Aono A, Ueno N, et al. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. Biochem Biophys Res Commun, 1995, 209: 859-866.
  • 5Aono A, Hazama M, Notoya K, et al. Potent ectopic boneinducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun, 1995, 210: 670-677.
  • 6Kusanagi K, Inoue H, Ishidou Y, et al. Characterization of a bone morphogenetic proteinresponsive smad-binding element. Mol Biol Cell, 2000, 11: 555-565.
  • 7Zhu W, RawlinsBA, Myers ER, et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. Journal of Bone and Mineral Research. 2004, 19(12): 2021-2031.
  • 8孙奋勇,汪炬,孙晋华,戴云,邱垂源,洪岸.重组人骨形成蛋白-2在大肠杆菌中的表达、纯化和复性(英文)[J].中国病理生理杂志,2005,21(8):1480-1485. 被引量：9
  • 9Massague J. How cells read TGF-b signals. Nature Rev. Mol. Cell Biol, 2000, 1: 169-178.
  • 10Itoh S, Itoh F, Goumans MJ. Signaling of transforming growth factor-b family members through Smad proteins. Eur J Biochem, 2000, 267: 6954-6967.

二级参考文献2

共引文献8

同被引文献46

  • 1BODEN S D, KANG J, SANDHU H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumb ized clinical [J]. Spine, n humans: a prospective, randompilot trial, 2002 Volvo Award in clinical studies 2002, 7(23) ,2662-2673.
  • 2GOVENDER S, CSIMMA C, GENANT H K, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures:a prospective, controlled, randomized study of four hundred and fifty patients[J]. J Bone Joint Surg Am, 2002, 84-A(12):2123-2134.
  • 3ZLOTOLOW D A, VACCARO A R, SALAMON M L, et al. The role of human bone morphogenetic proteins in spinal fusion[J].J Am Acad OrthopSurg, 2000, 8(1):8-9.
  • 4KANEKO H, ARAKAWA T, MANO H, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts[J].Bone, 2000, 27(4) :479-486.
  • 5AONO A, HAZAMA M, NOTOYA K, et al. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer[J]. Biochem Biophys Res Commun, 1995, 210(3): 670-677.
  • 6ISRAEL D I, NOVE J, KERNS K M, et al. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo[J]. Growth Factors, 1996, 13(3-4) :291-300.
  • 7ZHU W, RAWLINS B A, BOACHIE-ADJEI O, et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastle differentiation and spine fusion in a rodent model[J]. J Bone Miner Res, 2004, 19(12):2021-2032.
  • 8FRANCESCHI R T, YANG S, RUTHERFORD R B, et al. Gene therapy approaehes for bone regeneration[J]. Cells Tissues Organs, 2004, 176(1-3) :95-108.
  • 9ZHAO M, ZHAO Z, KOH J T, et al. Combinatorial gene therapy for bone regeneration: Cooperative interactions between adenovirus vectors expressing bone morphogenetie proteins 2, 4, and 7[J]. Journal of Cellular Biochemistry, 2005, 95(1) : 1-16.
  • 10KOH J T, ZHAO Z, WANG Z, et al. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration[J].J Dent Res, 2008, 87(9) :845-849.

引证文献4

二级引证文献9

生物工程学报
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部